Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: A pharmacodynamics perspective-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concomitant use of analgesics and immune checkpoint inhibitors in non-small cell lung cancer: A pharmacodynamics perspective

Published:2021-09 Issue: Volume:906 Page:174284
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Prasetya Rahmad Aji^ORCID,Metselaar-Albers Marjolein,Engels Ferdi

Publisher

Elsevier BV

Subject

Pharmacology

Reference68 articles.

1. Role of targeted therapy and immune checkpoint blockers in advanced non‐small cell lung cancer: a review;Abdel Karim;Oncol.,2019

2. Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients;Arrieta;Oncotarget,2017

3. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation;Banerjee;Mucosal Immunol.,2016

4. Influence of opioids on immune function in patients with cancer pain: from bench to bedside;Boland;Br. J. Pharmacol.,2018

5. T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional μ-opioid receptors;Börner;Mol. Pharmacol.,2008

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opioid Use and Gut Dysbiosis in Cancer Pain Patients;International Journal of Molecular Sciences;2024-07-22

2. Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors;Supportive Care in Cancer;2024-06-27

3. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data;Journal of Cancer Research and Clinical Oncology;2024-04-10

4. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients;International Immunopharmacology;2024-03

5. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: Analysis of Health Insurance Review and Assessment data;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3